Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Ronda Henry-Tillman

Concepts (256)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
39
2024
1181
4.810
 Why?
Early Detection of Cancer
6
2020
163
2.420
 Why?
Ultrasonography, Mammary
8
2020
61
2.070
 Why?
Mass Screening
3
2020
346
1.540
 Why?
Colorectal Neoplasms
4
2018
253
1.540
 Why?
Healthcare Disparities
3
2017
277
1.120
 Why?
Mastectomy
13
2019
141
1.100
 Why?
Mastectomy, Segmental
7
2018
92
1.080
 Why?
Sentinel Lymph Node Biopsy
10
2015
117
1.030
 Why?
Community Health Planning
3
2018
27
1.000
 Why?
Ultrasonography, Interventional
5
2020
137
0.850
 Why?
Biopsy, Needle
10
2015
181
0.850
 Why?
Focus Groups
1
2024
189
0.840
 Why?
Neoplasm Staging
14
2024
748
0.830
 Why?
Biopsy, Large-Core Needle
3
2020
31
0.830
 Why?
Female
55
2024
26520
0.790
 Why?
Genetic Counseling
1
2022
40
0.780
 Why?
Health Status Disparities
3
2015
196
0.770
 Why?
Neoplasms
5
2015
1233
0.760
 Why?
Lymph Nodes
7
2015
261
0.760
 Why?
Patient Education as Topic
1
2024
311
0.740
 Why?
Image Interpretation, Computer-Assisted
1
2020
105
0.690
 Why?
Middle Aged
40
2024
12258
0.680
 Why?
Image-Guided Biopsy
2
2020
33
0.670
 Why?
Hematoma
4
2018
64
0.660
 Why?
Surgery, Computer-Assisted
2
2018
54
0.650
 Why?
Polymorphism, Single Nucleotide
2
2018
483
0.630
 Why?
Humans
60
2024
49863
0.620
 Why?
Mandatory Programs
1
2018
21
0.610
 Why?
Adiposity
1
2019
132
0.590
 Why?
Faculty, Medical
3
2021
92
0.590
 Why?
Health Care Costs
1
2018
168
0.580
 Why?
Aged
31
2024
9434
0.570
 Why?
Adult
32
2024
13325
0.570
 Why?
Insurance Coverage
1
2018
109
0.560
 Why?
Disease Management
1
2018
175
0.540
 Why?
Diagnostic Imaging
1
2018
177
0.530
 Why?
Minority Groups
3
2015
131
0.520
 Why?
Arkansas
9
2018
1982
0.510
 Why?
Retrospective Studies
19
2022
6106
0.490
 Why?
Physicians
1
2018
227
0.480
 Why?
Health Planning Councils
1
2014
6
0.460
 Why?
Community-Based Participatory Research
2
2015
196
0.440
 Why?
Health Policy
1
2014
151
0.420
 Why?
Rural Population
1
2017
546
0.420
 Why?
Follow-Up Studies
11
2018
2174
0.410
 Why?
Aged, 80 and over
14
2018
3132
0.410
 Why?
Qualitative Research
3
2024
337
0.400
 Why?
Community Networks
2
2015
50
0.390
 Why?
Community-Institutional Relations
1
2011
46
0.390
 Why?
Primary Health Care
2
2024
361
0.390
 Why?
Carcinoma, Ductal, Breast
4
2015
89
0.380
 Why?
Carcinoma, Lobular
2
2015
33
0.370
 Why?
Population Surveillance
1
2012
160
0.370
 Why?
Physicians, Women
2
2021
22
0.360
 Why?
Neoplasm Recurrence, Local
6
2014
627
0.340
 Why?
Women's Health
1
2010
82
0.340
 Why?
Health Education
2
2008
153
0.330
 Why?
Needs Assessment
2
2024
133
0.330
 Why?
Medical Oncology
1
2010
95
0.320
 Why?
Breast Diseases
4
2018
27
0.320
 Why?
Nipples
5
2013
33
0.300
 Why?
Schools, Medical
2
2020
70
0.300
 Why?
Axilla
6
2015
89
0.290
 Why?
Health Knowledge, Attitudes, Practice
1
2012
488
0.290
 Why?
Socioeconomic Factors
3
2018
583
0.290
 Why?
Morbidity
2
2018
128
0.290
 Why?
Health Services Accessibility
1
2011
414
0.280
 Why?
Physician-Patient Relations
2
2012
143
0.270
 Why?
Catheter Ablation
4
2014
122
0.260
 Why?
Mammaplasty
3
2013
44
0.260
 Why?
Prognosis
9
2024
1948
0.260
 Why?
Mentors
1
2006
55
0.250
 Why?
Lymphatic Metastasis
7
2015
226
0.250
 Why?
Survivors
2
2024
120
0.250
 Why?
Occult Blood
2
2017
22
0.250
 Why?
United States
7
2022
4870
0.240
 Why?
Young Adult
5
2024
4013
0.230
 Why?
Magnetic Resonance Imaging
5
2014
1526
0.230
 Why?
Referral and Consultation
2
2024
285
0.220
 Why?
Education, Medical, Graduate
2
2022
210
0.220
 Why?
Technetium Tc 99m Sulfur Colloid
4
2008
31
0.210
 Why?
Male
13
2022
25439
0.200
 Why?
Empathy
1
2002
46
0.200
 Why?
Problem-Based Learning
1
2002
47
0.200
 Why?
Atrial Fibrillation
1
2024
182
0.190
 Why?
Emotions
1
2023
166
0.190
 Why?
Breast
2
2020
86
0.190
 Why?
Democratic Republic of the Congo
1
2020
4
0.190
 Why?
Genetic Testing
1
2022
119
0.190
 Why?
Dermatologic Surgical Procedures
3
2013
34
0.190
 Why?
Counseling
1
2022
131
0.180
 Why?
Combined Modality Therapy
4
2018
638
0.180
 Why?
Feasibility Studies
2
2020
382
0.180
 Why?
Biopsy, Fine-Needle
1
2020
108
0.180
 Why?
Research Support as Topic
1
2020
45
0.170
 Why?
Students, Medical
1
2002
158
0.170
 Why?
General Surgery
1
2021
106
0.170
 Why?
Surgical Flaps
2
2019
114
0.170
 Why?
Obesity
1
2008
1101
0.170
 Why?
Prospective Studies
10
2024
2341
0.160
 Why?
Incidence
2
2024
982
0.160
 Why?
Patient Satisfaction
2
2019
273
0.160
 Why?
Radiopharmaceuticals
4
2008
205
0.150
 Why?
Adipose Tissue
1
2019
186
0.150
 Why?
Logistic Models
2
2018
895
0.140
 Why?
Diagnosis, Differential
1
2020
1038
0.140
 Why?
Rural Health
1
2017
88
0.140
 Why?
Lymphatic Vessels
2
2008
53
0.140
 Why?
Odds Ratio
1
2018
547
0.140
 Why?
Internship and Residency
1
2022
442
0.140
 Why?
Zambia
3
2024
3
0.140
 Why?
Mammography
1
2016
98
0.130
 Why?
Rural Health Services
1
2018
168
0.130
 Why?
Cytodiagnosis
2
2013
42
0.130
 Why?
Genetic Predisposition to Disease
1
2018
507
0.130
 Why?
Case-Control Studies
1
2018
1129
0.120
 Why?
Risk Assessment
2
2018
1253
0.120
 Why?
Cross-Sectional Studies
3
2021
1568
0.120
 Why?
National Cancer Institute (U.S.)
1
2015
28
0.120
 Why?
Survival Rate
1
2017
904
0.120
 Why?
Uterine Cervical Neoplasms
1
2017
276
0.120
 Why?
Algorithms
1
2018
613
0.120
 Why?
Career Mobility
2
2021
28
0.110
 Why?
Patient Care Planning
1
2013
67
0.110
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
2013
42
0.110
 Why?
Monitoring, Intraoperative
3
2014
54
0.110
 Why?
Education, Medical
2
2006
112
0.100
 Why?
Sigmoidoscopy
1
2012
10
0.100
 Why?
Reagent Kits, Diagnostic
1
2012
18
0.100
 Why?
Health Services
1
2012
65
0.100
 Why?
Colonoscopy
1
2012
96
0.100
 Why?
Lymph Node Excision
4
2008
137
0.090
 Why?
Reproducibility of Results
1
2015
1180
0.090
 Why?
Feces
1
2012
131
0.090
 Why?
Treatment Outcome
9
2017
5165
0.090
 Why?
Receptors, Estrogen
2
2015
130
0.090
 Why?
Lymphedema
2
2008
43
0.090
 Why?
Pancreatic Neoplasms
1
2013
209
0.090
 Why?
Fructose
1
2010
22
0.090
 Why?
Clinical Competence
1
2013
393
0.090
 Why?
Registries
1
2013
522
0.090
 Why?
Patient Compliance
1
2012
230
0.090
 Why?
Carbon
1
2010
54
0.090
 Why?
Risk Factors
3
2024
3597
0.090
 Why?
History, 21st Century
1
2010
56
0.090
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
993
0.080
 Why?
Carcinoma in Situ
2
2006
73
0.080
 Why?
Patient Acceptance of Health Care
1
2012
336
0.080
 Why?
Delivery of Health Care
1
2011
308
0.080
 Why?
Models, Theoretical
2
2006
172
0.070
 Why?
Prochlorperazine
1
2006
6
0.070
 Why?
Postoperative Nausea and Vomiting
1
2006
20
0.070
 Why?
Education, Medical, Continuing
1
2006
68
0.070
 Why?
Sensitivity and Specificity
3
2004
855
0.070
 Why?
Antiemetics
1
2006
32
0.070
 Why?
Receptor, erbB-2
1
2006
74
0.070
 Why?
Body Weights and Measures
1
2005
17
0.060
 Why?
Predictive Value of Tests
2
2013
907
0.060
 Why?
Biopsy
2
2004
591
0.060
 Why?
Intraoperative Care
2
2003
51
0.060
 Why?
Gadolinium
1
2005
42
0.060
 Why?
Interprofessional Relations
1
2006
85
0.060
 Why?
Tissue Expansion Devices
1
2004
3
0.060
 Why?
Neuromuscular Agents
1
2004
7
0.060
 Why?
Neoadjuvant Therapy
2
2017
117
0.060
 Why?
Botulinum Toxins, Type A
1
2004
13
0.060
 Why?
Imaging, Three-Dimensional
1
2005
152
0.060
 Why?
Life Expectancy
1
2024
33
0.060
 Why?
Contrast Media
1
2005
186
0.060
 Why?
Cytological Techniques
1
2003
14
0.060
 Why?
Anthracyclines
1
2024
29
0.060
 Why?
Pain, Postoperative
1
2004
156
0.060
 Why?
Neoplasms, Multiple Primary
1
2003
43
0.060
 Why?
Neoplasm Grading
2
2014
123
0.050
 Why?
Preoperative Care
3
2014
167
0.050
 Why?
Surgical Instruments
1
2002
27
0.050
 Why?
Humanism
1
2002
8
0.050
 Why?
Life Change Events
1
2002
35
0.050
 Why?
Foreign-Body Migration
1
2002
32
0.050
 Why?
Confidence Intervals
1
2002
155
0.050
 Why?
Career Choice
1
2002
110
0.050
 Why?
Program Development
1
2002
162
0.050
 Why?
Sexism
1
2021
10
0.050
 Why?
Image Processing, Computer-Assisted
1
2002
242
0.050
 Why?
Leadership
1
2021
101
0.040
 Why?
Neoplasm Invasiveness
2
2010
268
0.040
 Why?
Vacuum
2
2011
13
0.040
 Why?
Curriculum
1
2002
397
0.040
 Why?
Stereotaxic Techniques
2
2010
37
0.040
 Why?
Angiopoietin-2
1
2017
15
0.040
 Why?
Angiopoietin-1
1
2017
16
0.040
 Why?
Receptor, TIE-2
1
2017
16
0.040
 Why?
Fibroblast Growth Factor 2
1
2017
34
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2017
44
0.040
 Why?
Gene Frequency
1
2017
96
0.030
 Why?
Injections, Intralesional
2
2008
31
0.030
 Why?
Matrix Metalloproteinase 9
1
2017
89
0.030
 Why?
Adolescent
3
2013
6392
0.030
 Why?
Guidelines as Topic
1
2016
110
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
201
0.030
 Why?
Regression Analysis
1
2017
385
0.030
 Why?
Neovascularization, Pathologic
1
2017
158
0.030
 Why?
Coloring Agents
2
2007
67
0.030
 Why?
Radionuclide Imaging
2
2007
116
0.030
 Why?
Educational Status
1
2016
222
0.030
 Why?
Genotype
1
2017
534
0.030
 Why?
Taxoids
1
2015
37
0.030
 Why?
Receptors, Progesterone
1
2015
63
0.030
 Why?
Cohort Studies
2
2011
1400
0.030
 Why?
Cyclophosphamide
1
2015
163
0.030
 Why?
Touch
1
2013
25
0.030
 Why?
Ultrasonography, Doppler
1
2014
41
0.030
 Why?
Carcinoma
1
2015
139
0.030
 Why?
Angiogenesis Inhibitors
1
2015
187
0.030
 Why?
Antibodies, Monoclonal, Humanized
1
2015
225
0.030
 Why?
Disease-Free Survival
1
2014
452
0.030
 Why?
Kaplan-Meier Estimate
1
2014
463
0.030
 Why?
Cicatrix
1
2011
39
0.020
 Why?
Microscopy, Phase-Contrast
1
2010
12
0.020
 Why?
Plant Lectins
1
2010
8
0.020
 Why?
Glycosylation
1
2010
102
0.020
 Why?
Substrate Specificity
1
2010
192
0.020
 Why?
Actins
1
2010
115
0.020
 Why?
Tumor Cells, Cultured
1
2010
460
0.020
 Why?
Cell Movement
1
2010
245
0.020
 Why?
Breast Neoplasms, Male
1
2009
6
0.020
 Why?
Pilot Projects
1
2011
700
0.020
 Why?
Arm
1
2008
47
0.020
 Why?
Phenotype
1
2010
727
0.020
 Why?
Cost-Benefit Analysis
1
2008
269
0.020
 Why?
Positron-Emission Tomography
1
2008
288
0.020
 Why?
Administration, Rectal
1
2006
10
0.020
 Why?
Cell Line, Tumor
1
2010
1387
0.020
 Why?
Probability
1
2006
162
0.020
 Why?
Primary Prevention
1
2006
44
0.020
 Why?
Drug Administration Schedule
1
2006
370
0.020
 Why?
Administration, Oral
1
2006
432
0.020
 Why?
Carcinoma, Ductal
1
2004
9
0.020
 Why?
Tissue Expansion
1
2004
4
0.020
 Why?
Pectoralis Muscles
1
2004
6
0.020
 Why?
Rectus Abdominis
1
2004
7
0.020
 Why?
Spasm
1
2004
9
0.020
 Why?
Laser Coagulation
1
2004
26
0.010
 Why?
Multivariate Analysis
1
2006
577
0.010
 Why?
Cryosurgery
1
2004
35
0.010
 Why?
Sampling Studies
1
2004
37
0.010
 Why?
Statistics, Nonparametric
1
2004
193
0.010
 Why?
Chi-Square Distribution
1
2004
275
0.010
 Why?
Injections
1
2003
56
0.010
 Why?
Pain Measurement
1
2004
246
0.010
 Why?
Ultrasonography
1
2004
428
0.010
 Why?
Dose-Response Relationship, Drug
1
2006
1354
0.010
 Why?
Length of Stay
1
2004
623
0.010
 Why?
Reoperation
1
2002
451
0.010
 Why?
Analgesics, Opioid
1
2004
553
0.010
 Why?
Henry-Tillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (256) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (30) people
_
Same Department Expand Description
Search Department